IRIS
FEZZA, FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.753
EU - Europa 1.327
AS - Asia 626
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AF - Africa 2
Totale 21.732
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.745
SG - Singapore 391
UA - Ucraina 256
DE - Germania 186
IE - Irlanda 183
CN - Cina 150
IT - Italia 147
RU - Federazione Russa 119
SE - Svezia 98
FR - Francia 86
PL - Polonia 80
GB - Regno Unito 67
FI - Finlandia 58
KR - Corea 55
BE - Belgio 13
CZ - Repubblica Ceca 11
BR - Brasile 7
CA - Canada 6
EU - Europa 6
HU - Ungheria 6
JP - Giappone 6
KG - Kirghizistan 6
ES - Italia 5
IL - Israele 5
IR - Iran 5
AU - Australia 4
CL - Cile 3
GR - Grecia 3
HK - Hong Kong 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
MY - Malesia 2
NL - Olanda 2
SC - Seychelles 2
DK - Danimarca 1
DM - Dominica 1
EC - Ecuador 1
ID - Indonesia 1
IN - India 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
Totale 21.732
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.872
Wilmington 5.457
Houston 4.718
Fairfield 673
Ann Arbor 481
Chandler 370
Singapore 351
Seattle 271
Ashburn 257
Jacksonville 245
Cambridge 223
Dublin 179
Medford 145
Dearborn 121
Santa Clara 81
Kraków 78
Lawrence 66
Beijing 64
Mülheim 39
New York 39
San Diego 30
Rome 29
Menlo Park 28
Moscow 19
San Mateo 16
Boardman 15
Brussels 13
Milan 13
Munich 13
Brno 11
Los Angeles 11
Verona 11
Zhengzhou 11
London 10
Redwood City 9
Hefei 7
Nanjing 7
Saint Petersburg 7
Shanghai 7
Chicago 6
Detroit 6
Falls Church 6
Kunming 6
Palo Alto 6
Berlin 5
Cagliari 5
Helsinki 5
University Park 5
Auburn Hills 4
Guangzhou 4
Justice 4
Miskolc 4
Mountain View 4
Naples 4
Norwalk 4
Nürnberg 4
Redmond 4
Seoul 4
Siena 4
São Paulo 4
Catania 3
Gainesville 3
Indiana 3
San Francisco 3
Toronto 3
Wenzhou 3
Ypsilanti 3
Agliana 2
Budapest 2
Changsha 2
Dongguan 2
Garden City 2
Guiyang 2
Hangzhou 2
Hong Kong 2
Hounslow 2
Jinan 2
Lappeenranta 2
Napoli 2
Ningbo 2
Pianella 2
Sant'Angelo del Pesco 2
Suceava 2
Tel Aviv 2
Venafro 2
Adelaide 1
Amsterdam 1
Athens 1
Auckland 1
Augusta 1
Bari 1
Baulkham Hills 1
Caserta 1
Central 1
Changchun 1
Changzhou 1
Chaoyang 1
Chatsworth 1
Chisinau 1
Chiswick 1
Totale 20.167
Salva come PNG Salva come JPEG
Nome #
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase 485
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity 458
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction 440
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake 439
The anandamide membrane transporter and the therapeutic implications of its inhibition 437
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins 435
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. 435
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. 430
Endocannabinoids, related compounds and their metabolic routes 425
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 424
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol 423
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. 421
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 420
Mouse blastocyts release a lipid which activates anandamide hydrolase in intact uterus 414
Evidence for the intracellular accumulation of anandamide in adiposomes 411
New insights into endocannabinoid degradation and its therapeutic potential 406
Methods to assay anandamide hydrolysis and transport in synaptosomes. 405
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 405
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 401
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 400
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. 399
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. 397
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. 396
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 395
Levels of N-Acylethanolamines in Human Tumors: In Search of Reliable Data 394
Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. 393
null 393
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid 391
Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system 391
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 391
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation 390
Endocannabinoid biochemistry: What do we know after 50 years? 390
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 390
Endocannabinoids and their involvement in the neurovascular system. 389
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 385
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. 385
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17 beta-estradiol 383
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes 382
Pitfalls and solutions in assaying anandamide transport in cells. 381
Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone 380
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus 374
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. 373
The endocannabinoid system in neurodegeneration. 372
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis 371
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 361
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 354
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 352
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 345
Rat and human fatty acid amide hydrolases: overt similarities and hidden differences. 339
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism 336
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells 323
Regulation of endocannabinoid system by lipid rafts along the neuroimmune axis 198
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 162
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 136
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 127
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 115
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 114
The endocannabinoid hydrolase FAAH is an allosteric enzyme 108
Assay of NAPE-PLD Activity 105
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 97
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 83
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 82
Plant-Derived and Endogenous Cannabinoids in Epilepsy 76
Bisphenol a deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin b production 49
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 36
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 31
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 22
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 19
Endocannabinoids and platelets - Signalling pathways 17
Endocannabinoids and platelets - Differentiation 17
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 16
Radiometric Assay of NAPE-PLD Activity 15
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 4
Totale 21.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.136
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.427 0 0 0 0 0 585 493 506 534 424 447 438
2020/20213.658 419 480 394 455 420 434 395 346 63 81 129 42
2021/2022665 22 80 37 22 18 44 36 19 52 74 45 216
2022/2023930 108 82 45 123 70 203 61 59 83 4 68 24
2023/2024230 37 11 11 17 18 55 6 9 10 3 13 40
2024/2025759 74 348 194 90 25 28 0 0 0 0 0 0
Totale 21.838